Pharma & Biotech

Pharmaceutical titan Eli Lilly has launched an aggressive offensive in the lucrative weight-loss drug sector, initiating a price war that...

The shares of Viking Therapeutics have delivered a remarkable 34% gain over the past three months, signaling a powerful resurgence....

The pharmaceutical titan Eli Lilly has escalated competition in the high-growth weight-loss medication sector with a bold pricing maneuver. By...

A significant shift in analyst sentiment is casting a shadow over Intellia Therapeutics, sending its stock downward and prompting investors...

Shares of healthcare distributor Henry Schein are trading lower in the current session, despite the company announcing two significant strategic...

A major strategic alliance and a wave of bullish analyst revisions are fueling a significant rally in Iqvia Holdings Inc....

Despite a recent share price decline, Summit Therapeutics finds itself at a pivotal moment, with significant insider purchases and bullish...

Biotechnology firm Codexis finds itself navigating a critical transition. Recent quarterly results paint a picture of significant revenue contraction, even...

Biotechnology firm Ocugen is facing intense selling pressure, with its stock price declining sharply in recent sessions. On Monday, the...

IO Biotech finds itself at a pivotal moment. As CEO Mai-Britt Zocca addresses investors at the Evercore Healthcare Conference, the...